Search the Archive

Medicine: Diabetes and Avandia #861341

CBS Evening News for Monday, May 21, 2007
View other clips in this broadcast →

Material supplied by VTNA may be used for educational analysis or research only. Any editing, reproduction, publication, rebroadcast, public showing or public display may be prohibited by copyright laws.

(Studio: Katie Couric) Reports introduced.

(Washington: Wyatt Andrews) The bombshell from the Cleveland Clinic linking Avandia, the "wonder drug" for treating type II diabetes, to heart problems examined; details given from the response of the FDA and drugmaker GlaxoSmithKline. [Cleveland Clinic Dr. Steven NISSEN†- says it is most urgent the company and FDA do analyses of the drug; offers patient advice.] [Representative Henry WAXMAN - wants to hear from the FDA.]

(Studio: Katie Couric, Jon LaPook) How Avandia works, other medication options, the lack of clarity about this study and the need for a large study over a number of years discussed.

Reporter(s):
Couric, Katie;
Andrews, Wyatt;
LaPook, Jon
Duration:
00:03:50

Note to sponsor members: The Vanderbilt Television News Archive video player requires a modern operating system and browser to work properly. If you are experiencing playback problems, check the minimum requirements and adjust your setup accordingly. After adjustments, if you continue to experience problems, please contact us.

Welcome! Above is the abstract of the item that you're interested in viewing from the Vanderbilt Television News Archive's collection. You have three options if you'd like to view this item:

  • You may request a loan of this video by registering on our website and placing an order.
  • You may visit the Television News Archive on the Vanderbilt campus to view on-site from the Archive's collection.
  • If you are associated with a college or university, you may ask your library if they would like to become a sponsor, which would give students and faculty at your institution the ability to view items from our collection.

If you believe that you are associated with a sponsoring college or university and have received this message in error, please let us know.